Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 3Burkitt Lymphoma 3Neuroblastoma 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia, Biphenotypic, Acute 2Leukemia 2Ganglioneuroblastoma 2Smoldering Multiple Myeloma 1Rhabdoid Tumor 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Medulloblastoma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myelomonocytic, Juvenile 1Immunoglobulin Light-chain Amyloidosis 1Hemoglobinuria, Paroxysmal 1Hemoglobinuria 1Breast Neoplasms 1

Interventions

pegaspargase 4Vincristine 4Doxorubicin 4Cytarabine 4Cyclophosphamide 4merphos 3dexamethasone acetate 3dexamethasone 21-phosphate 3azathiopurine 3auricularum 3Thioguanine 3Radiotherapy 3Methotrexate 3Mercaptopurine 3Leucovorin 3Dexamethasone 3Daunorubicin 3Calcium Dobesilate 3Asparaginase 3nelarabine 2liposomal amphotericin B 2calaspargase pegol 2Radiation 2Prednisone 2Levofloxacin 2Ifosfamide 2Hydrocortisone 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Stem Cell Transplantation × Clear all
NCT03007147 2026-05-04

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Active not recruiting
475 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡